Cassia Cearley - 15 Nov 2021 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Business Officer
Signature
/s/ Thomas Russo, Attorney-in Fact
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
+$18,756
Form type
4
Filing time
17 Nov 2021, 16:13:51 UTC
Previous filing
02 Aug 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $18,756 +22,598 +36% $0.8300* 85,491 15 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -22,598 -26% $0.000000 62,750 15 Nov 2021 Common Stock 22,598 $0.8300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on 12/2/2020, and 1/48th of the shares subject to the option vest monthly thereafter.